Northeastern Reproductive Medicine

Vermont Fertility Services Including IVF, Egg Donation and Fertility Preservation

  • Patient Portal
  • Donor Portal
  • 1 (802) 655-8888

Schedule A Consultation
  • Home
  • About
    • About Us
    • Our Physicians
    • Meet Our Team
    • Our Facilities
      • Laboratory
      • Ultrasound
  • Services
    • Fertility Testing
    • Basic Fertility Treatment
    • Carrier Screening
    • In Vitro Fertilization (IVF)
      • Intra-Cytoplasmic Sperm Injection (ICSI)
    • Pre-Implantation Genetic Screening and Diagnosis
    • Gender Selection
    • Donor Egg IVF – Overview for Intended Parents
    • Gestational Surrogate
    • LGBTQAI+ Family Building
    • Fertility Preservation
  • Success Stories
  • Financial Info
    • Insurance Information
    • Payments
  • Patient Info
    • Unexplained Infertility
    • Fertility Preservation
    • Bloodwork Screening Protocol
    • Genetic Carrier Screening
    • Letrozole
    • Antidepressant Use in Pregnancy
    • Understanding Recurrent Pregnancy
    • Thyroid Function in Pregnancy
    • Embryo Grading and Development
    • Varicella and Immunity
    • Rubella and Immunity
    • Female Fertility Supplements
    • Male Fertility Supplements
    • Vitamin D
    • Third Party Reproduction
    • Egg Donor Options
    • Gestational Carriers FAQs
    • Cytomegalovirus FAQs
    • Traveling to Vermont
    • Canadian Patients
    • Join Our Fertiility Family
    • FAQs
  • Egg Donors
    • Overview for Intended Parents
    • Overview for Donors
    • Donor Submission Form
  • Blog
  • Contact

Pre-Implantation Genetic Screening and Diagnosis

Pre-implantation Genetic Diagnosis (PGD)NRM is the only clinic in Vermont offering Pre-implantation Genetic Screening (PGS), a state-of-the-art procedure utilized when undergoing IVF to select embryos free of chromosomal abnormalities. PGS can improve the likelihood of IVF success and healthy pregnancy.

NRM also offers pre-implantation genetic diagnosis (PGD), for individuals or couples who are known carriers of a specific genetic disease, such as Cystic Fibrosis, Spinal Muscular Atrophy, or other single gene disorders. PGD allows identification of genetic disease to avoid passing the genetic disorder to offspring.


What are the types of PGS/PGD and who should consider?

PGS for chromosomal screening

  • Women with infertility related to recurrent miscarriage
  • Women with previously unsuccessful IVF cycles
  • Women of advanced reproductive age

PGD for chromosomal rearrangements

  • Individuals who carry known chromosomal rearrangements such as translocations or inversions

PGD for single gene disorders

  • Individuals or couples who carry a gene(s) for a specific genetic disorder (such as cystic fibrosis, spinal muscular atrophy, Tay-Sachs disease, fragile X syndrome, etc)
  • Not sure if you’re a carrier of a single gene disorder? NRM is the only clinic in Vermont offering pan-ethnic carrier screening with GoodStart technology called next-generation DNA sequencing (NGS).

What is a “normal” embryo?

One of the hardest decisions in IVF is identifying which embryo(s) to transfer. In the past due to this unknown, multiple embryos (often up to 3-5!) would be transferred in an effort to maximize chances of success, but this increased the risk of multiple pregnancy—often a tremendous risk to the likelihood of pregnancy success and healthy babies. Click here for ASRM Bulletin. In order to choose the best embryo to transfer, we utilize the latest technology to screen chromosomes—PGS—allowing us to learn more about the genetic competency of embryos.

What you need to know about PGS for chromosomal screening:

  • Normally, there are 23 pairs of chromosomes in each human cell, for a total of 46 chromosomes. This is referred to as euploidy.
  • One pair of each (23 chromosomes) comes from the mother the father.
  • Although you and your spouse are likely to be genetically normal, when the egg matures or the embryo develops, errors may occur in the chromosome number of your embryo. This is called aneuploidy and is more common as women age.

Aneuploidy is the most common reason for:

  • Failure of pregnancy to occur despite a normal-appearing embryo
  • Biochemical pregnancy loss (an initial pregnancy as seen by +bHCG testing which then fails to develop)
  • Miscarriage
  • Chromosomally affected infant (such as Trisomy 13,18, and 21 “Down’s Syndrome”)

By testing embryos for chromosomal aneuploidy prior to embryo transfer, we improve our ability to select the best embryos for transfer, in an effort to increase your pregnancy rate.

What is the process of PGS/PGD?

If you or your partner carry a known genetic disorder, the first step is to work with your physician and the genetics laboratory to set-up a probe that can detect the gene of concern. If you are undergoing PGS (for screening purposes), the first step is preparing for an IVF cycle.

Following IVF with ICSI, the first step is embryo biopsy. We have highly experienced embryologists who can perform microsurgical removal of one cell from a 3-day old or a few cells from a 5or 6-day old embryo. The biopsied cells are then placed in special containers in dry ice, and sent to a central PGS/PGD laboratory where each sample is analyzed independently.

We prefer to obtain testing cells from the embryo through a blastocyst (day-5) biopsy, because at this stage the inner cell mass, which will develop into the fetus, has differentiated from the trophectoderm, which will later develop into the placenta and membranes. A biopsy at this stage involves the removal of a number of cells (3-10) from the trophectoderm. This type of biopsy is advantageous in that no cells are extracted from the inner cell mass, while still obtaining multiple cells for carrying out PGS, which leads to improved accuracy. Furthermore, blastocysts are more robust than earlier embryonic stages and tolerate biopsy exceptionally well. The blastocyst also is the best stage for vitrification (flash freezing, into a “glass-like” state) with a 95% survival rate.

What can we learn from PGS/PGD?

  1. Obtain a 24-chromosome assessment in embryos with updated technology.
  2. Detect chromosomal rearrangements such as reciprocal/Robertsonian translocations and pericentric and paracentric inversions which are well-recognized forms of genetic abnormality.
  3. Detect known genetic disease with an identified mutation—PGD can be combined with your PGS cycle if needed. Preparation for this specific test is necessary prior to starting your IVF cycle (see above.)
  4. Determine gender of embryos for family balancing purposes.

What is NOT tested with PGS or PGD?

  • Birth defects (all newborns have approximately 3% risk for a congenital abnormality—“birth defect”—unrelated to known genes or disorders.)
  • All genetic disorders. This technology does not allow us to screen for all genetic disorders. If you have a known specific genetic disorder, you must plan specifically for PGD, examining embryos to determine if they carry the same genetic disorder that you carry.
  • Smaller chromosomal errors.

Why choose NRM for PGS/PGD?

  • Minimize your chances of passing along a known genetic disease to your children.
  • Potentially improve your chances of IVF success and minimize your chance of miscarriage.
  • Improve your ability to select a single embryo to transfer, thus minimizing your risk of twins or higher-order multiple pregnancy.
  • Your embryos will be biopsied by experienced embryologists, and testing will be performed using state of the art technology in order to get you accurate results in a timely and cost effective manner.

For more information on multiple pregnancy (twin, triplet and higher-order gestations), click here.

When you are ready, the next step is to schedule a consultation where we can meet with you and develop a personalized fertility plan designed to deliver the family of your dreams.

Schedule A Consultation

Insemination

Our Lab Services

Northeastern Reproductive Medicine Laboratories uses the most up-to-date techniques and equipment to aid in the evaluation and treatment of infertility. Learn about our Lab »

Carrier Screening

GoodStart® Carrier Screening

NRM has partnered with GoodStart Genetics to offer our patients the most advanced technology available to screen for genetic disease. Learn more »

Fertility Preservation Services

NRM offers freezing and storage of eggs, sperm, or embryos for individuals with a recent cancer diagnosis who desire future fertility, or those who elect to delay childbearing for other reasons.

  • Egg Freeze
  • Sperm Freeze

Referring Providers: Did you Know?

We want to work with you toward a common shared goal: maximizing reproductive health and increasing patients’ potential for successful pregnancies. We offer a set of referral services designed to help your patients take the first steps of fertility treatment Learn More.

Northeastern Reproductive Medicine

105 West View Road Suite 302
Colchester, Vermont 05446
1 (802) 655-8888

nrm-map

ASRM
Royal College
ABOG
ACOG
resolve
College of American Pathologists
Health First

  • Patient Portal
  • Donor Portal


Copyright © 2023 · Northeastern Reproductive Medicine — 105 West View Road Suite 302, Colchester, Vermont 05446